The Study
Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells
This study looked at cancer cells in a dish under special lab conditions and saw that when you take away sugar, the cells change how they use another nutrient called glutamine. It shows a pattern, but it doesn't prove that one thing causes another — it just says they happened together in the lab.
Analysis score
Maximum 44 for a cross-sectional study.
Where the score came from
Some pancreatic cancer cells with extra MUC1 protein get confused when sugar runs low — they suck up more glutamine but can't use it to make DNA, so they stop dividing.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 57 / 100
Quality score
Snapshots of a population at a single point in time, or descriptions of small groups. Can identify correlations and prevalence, but cannot determine cause and effect.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — this means these cancer cells are extra vulnerable to low sugar environments, which could be exploited to stop their growth.
- 2MUC1-overexpressing cells dropped from 24.3% to 6% in DNA-synthesis phase (S-phase) under low sugar — a 4.3x bigger drop than normal cells.
- 3Glutamine became the main source for building blocks, but those blocks piled up as aspartate instead of becoming DNA.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Journal of Proteome Research
Year
2017
Authors
Teklab Gebregiworgis, Vinee Purohit, Surendra K. Shukla, Saber Tadros, Nina V. Chaika, Jaime Abrego, Scott E. Mulder, Venugopal Gunda, Pankaj K. Singh, Robert Powers
Related Content
Claims (6)
When glucose is scarce, some cancer cells continue to grow by using glutamine as a substitute energy source.
Pancreatic cancer cells with high levels of MUC1 protein show a stronger reduction in cell division and a greater block in the G1 phase when glucose is restricted, compared to cancer cells without high MUC1 levels.
In pancreatic cancer cells, whether or not they overexpress MUC1, oxaloacetate in the TCA cycle is primarily derived from glutamine rather than glucose, regardless of glucose availability, demonstrating that glutamine is essential for biosynthetic processes in these cells.
When glucose is scarce, pancreatic cancer cells with high levels of MUC1 build up a molecule called aspartate from glutamine but cannot use it to make DNA building blocks, which stops the cells from multiplying.
In pancreatic cancer cells with high levels of MUC1 protein and low glucose, changes in how glutamine is processed cause aspartate to build up and pyrimidine production to drop, which stops the cells from dividing.
When glucose is limited, pancreatic cancer cells with high levels of MUC1 protein take up more glutamine than cancer cells without high MUC1 levels, showing that MUC1 changes how these cells respond to low glucose conditions.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.